About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us
More Company News
Scancell
Encouraging early efficacy data from ModiFY trial
21 Feb 2023
Read More
Scancell
Positive response in COVIDITY trial
13 Feb 2023
Read More
Scancell
Dr Jean-Michel Cosséry appointed Chairman
01 Feb 2023
Read More
Scancell
H123 interim results
25 Jan 2023
Read More
Scancell
Vaccitech technology licenced to advance Modi-2
07 Nov 2022
Read More
Scancell
First patient dosed in expansion phase of ModiFY
31 Oct 2022
Read More
Scancell
FY22 results for year ended 30 April 2022
28 Oct 2022
Read More
Scancell
Directorate changes
26 Oct 2022
Read More
Scancell
Commercial licence agreement with Genmab
25 Oct 2022
Read More
Scancell
Change of NOMAD
13 Oct 2022
Read More
1
2
3
4
…
8
Return to Scancell
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us